Glycosylated Fibronectin in Fetal Growth Restriction: An Emerging Biomarker of Placental Dysfunction
Cureus · 28.07.2026
DOI: 10.7759/cureus.113553 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 28.07.2026. Verfasst von Dimitrios I Karoutsos und 6 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Obstetrics and Gynecology, Alexandra Hospital, Athens, GRC. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 1st Department of Obstetrics and Gynecology, Alexandra Hospital, Athens, GRC.
Zitieren
APA
Karoutsos, D. I., Stefanidis, K., Michala, L., Antsaklis, P., Mavrogianni, D., Asimakopoulos, G., & Daskalakis, G. (2026). Glycosylated Fibronectin in Fetal Growth Restriction: An Emerging Biomarker of Placental Dysfunction. Cureus. https://doi.org/10.7759/cureus.113553
Vancouver
Karoutsos DI, Stefanidis K, Michala L, Antsaklis P, Mavrogianni D, Asimakopoulos G, et al. Glycosylated Fibronectin in Fetal Growth Restriction: An Emerging Biomarker of Placental Dysfunction. Cureus. 2026. doi:10.7759/cureus.113553
BibTeX
@article{Karoutsos2026,
author = {Karoutsos, Dimitrios I and Stefanidis, Konstantinos and Michala, Lina and Antsaklis, Panagiotis and Mavrogianni, Despoina and Asimakopoulos, Georgios and Daskalakis, Georgios},
title = {Glycosylated Fibronectin in Fetal Growth Restriction: An Emerging Biomarker of Placental Dysfunction},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.113553}
}
EUVIMED